Press release
Orthofix to Participate in Canaccord Genuity's 44th Annual Growth Conference
Wednesday, August 14, 2024 at 2:30 pm Eastern Time LEWISVILLE, Texas--(BUSINESS WIRE)-- Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and
About this update from Orthofix Medical Inc.
[{"type":"text","content":"\nWednesday, August 14, 2024 at 2:30 pm Eastern Time\n\n\n LEWISVILLE, Texas--(BUSINESS WIRE)--\nOrthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that the Company will participate in Canaccord Genuity's 44th Annual Growth Conference in Boston. Management is scheduled to present on Wednesday, August 14, 2024 at 2:30 pm ET.\n\n\nInterested parties can access the live and archived webcast of the presentation on the Investors section of the Orthofix website at ir.orthofix.com.\n\n\nInternet Posting of Information\n\n\nOrthofix routinely posts information that may be important to investors in the “Investor Relations” section of its website at www.orthofix.com. The Company encourages investors and potential investors to consult the Orthofix website regularly for important information about Orthofix.\n\n\nAbout Orthofix\n\n\nOrthofix is a leading global spine and orthopedics company with a comprehensive portfolio of biologics, innovative spinal hardware, bone growth therapies, specialized orthopedic solutions, and a leading surgical navigation system. Its products are distributed in more than 60 countries worldwide. The Company is headquartered in Lewisville, Texas, where it conducts general business, product development, medical education and manufacturing, and has primary offices in Carlsbad, CA, with a focus on spine and biologics product innovation and surgeon education, and Verona, Italy, with an emphasis on product innovation, production, and medical education for orthopedics. The combined Company’s global R&D, commercial and manufacturing footprint also includes facilities and offices in Irvine, CA, Toronto, Canada, Sunnyvale, CA, Maidenhead, UK, Munich, Germany, Paris, France and São Paulo, Brazil.\n\nView source version on businesswire.com: https://www.businesswire.com/news/home/20240717588160/en/\n\nInvestor Relations\nJulie Dewey\[email protected]\n209.613.6945\n\n\nMedia Relations\nDenise Landry\[email protected]\n214.937.2529\n\n\nSource: Orthofix Medical Inc.","length":4679,"tagName":"div"}]